ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Antioxidant supplement may boost chemo in advanced lung cancer
Disease control Not yet recruitingThis study tests whether adding a daily dose of alpha lipoic acid (an antioxidant supplement) to standard chemotherapy can help people with advanced non-small cell lung cancer (stage III or IV). The goal is to see if it improves tumor response, slows disease progression, and exte…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Timing is everything: new lung cancer trial aims to boost treatment by scheduling infusions just right
Disease control Not yet recruitingThis study tests whether giving immunotherapy and chemotherapy at different times can help people with advanced non-small cell lung cancer (NSCLC) that lacks certain gene mutations. About 246 adults will be split into three groups: same-day treatment, chemotherapy two days before…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated May 12, 2026 13:42 UTC